<DOC>
	<DOCNO>NCT00502021</DOCNO>
	<brief_summary>Preliminary study show flaxseed powder , rich omega-3 alpha-linolenic acid , beneficial general inflammation present morbidly obese subject decrease elevate serum markers.As omega-3 fatty acid display additional property include possible amelioration atherosclerosis , 3-month supplementation protocol devised.Arterial stiffness intima thickness measure severely obese subject , order document possible reduction variable well .</brief_summary>
	<brief_title>Use Flaxseed ( Alpha Linolenic Acid ) Powder Morbidly Obese Patients With Systemic Inflammation</brief_title>
	<detailed_description>Population : Morbidly obese non-smoking patient Department Gastroenterology , candidate possible bariatric treatment Criteria inclusion : Males female , 18- 65 year old , body mass index/BMI &gt; 40 kg/m2 ( &gt; 35 kg/m2 comorbidities ) , non-hospitalized receive general oral diet , elevate C-reactive protein/ CRP ( &gt; 5mg/L ) , sign informed consent ; Criteria exclusion : SIRS , shock , coma organ failure , fever infectious focus , cancer without chemo/radiotherapy , inflammatory illness ( rhematic , gastrointestinal ) , transplantation immunologic disease , trauma , surgery hospitalization last 30 day , use steroidal non-steroidal anti-inflammatory immune-modulating agent antibiotic , refusal participate study ; Dietetic routine : Daily flaxseed powder ( Farinha de linhaca dourada ) 60 g/day ( 232 kcal , contain 10 g alpha-linolenic acid/ALA ) placebo ( commercial manioc flour 60 g/day , 120 kcal ) ) 12 week . An additional 60 subject ( 30 patient , 30 control ) manage 30 ml/day flaxseed oil ( 10 g alpha-linolenic acid/ALA ) 30 ml/day placebo ( safflower oil ) . Methods : Clinical questionnaire , nutritional assessment ( Weight , height , BMI ) Biochemical test : Hemoglobin ( HB ) , white blood cell count ( WBC ) , total cholesterol ( CHOL ) fraction ( HDL , LDL , VLDL ) , triglyceride ( TRIG ) , blood glucose ( GLU ) , serum albumin ( ALB ) , insulin ( INS ) , leptin ( LEP ) , C-reactive protein ( CRP ) , serum amyloid A ( SAA ) , complement fraction C3 C4 , coagulation profile Atherosclerosis marker : Arterial stiffness ( aorta ) intima thickness ( common carotid artery )</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>Males females 18 65 year old Body mass index/BMI &gt; 40 kg/m2 ( &gt; 35 kg/m2 comorbidities ) Nonhospitalized receive general oral diet With elevated Creactive protein/ CRP ( &gt; 5mg/L ) ; Signing informed consent SIRS , shock , coma organ failure , Fever infectious focus Cancer without chemo/radiotherapy Inflammatory illness ( rhematic , gastrointestinal ) , transplantation immunologic diseases Trauma , surgery hospitalization last 30 day Use steroidal nonsteroidal antiinflammatory immunemodulating agent antibiotic ; Refusal participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>obesity</keyword>
	<keyword>alpha linolenic acid</keyword>
	<keyword>flaxseed</keyword>
	<keyword>C-reactive protein</keyword>
	<keyword>inflammation</keyword>
</DOC>